Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever
Authors:
- D.B. WallaceDWD.B. Wallace
- C.E. EllisCEC.E. Ellis
- A. EspachAEA. Espach
- S.J. SmithSSS.J. Smith
- R.R. GreylingRGR.R. Greyling
- G.J. ViljoenGVG.J. Viljoen
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virusVaccine, 2006
- Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertionVaccine, 2005
- Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vectorJournal of General Virology, 2003
- Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin diseaseVaccine, 1993
- Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in ratsVaccine, 1991
- Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheepVaccine, 1991
- Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccineVaccine, 1990
- Humoral and cell‐mediated immune responses to recombinant vaccinia viruses in miceImmunology & Cell Biology, 1989
- The characterization of African strains of capripoxvirusEpidemiology and Infection, 1989
- An epizootic of Rift Valley fever in Egypt in 1977Veterinary Record, 1979